Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting

Go back to Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
(NASDAQ: IMUX) Delayed: 7.48 --0 (-0%)
Previous Close $7.48    52 Week High $ 
Open $7.48    52 Week Low $ 
Day High $7.48    P/E N/A 
Day Low $7.48    EPS $ 
Volume 88